BRUKER CORP (BRKR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BRKR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BRKR | Director | 60 | ["President & CEO of Accelerate Diagnostics from 2020-2025","President & CEO of Roche Diagnostics North America from 2010-2020","Senior VP and General Manager, North America, for Ventana Medical Systems from 1999-2010","B.S. in Marketing from Northern Kentucky University"] | ["Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Phillips served as President & CEO of Accelerate Diagnostics from 2020-2025, pioneering rapid antibiotic susceptibility testing ( AST ) technology for hospitals and infectious disease doctors combating serious bacterial infections, life-threatening sepsis, and antibiotic resistance. Previously, Mr. Phillips was President & CEO of Roche Diagnostics North America from 2010-2020, where he led the portfolio across clinical chemistry, immunodiagnostics, as well as molecular, tissue and point-of-care diagnostics, and digital pathology, all further strengthening Roche s leadership position in the global in vitro diagnostics ( IVD ) industry. From 1999-2010, Mr. Phillips was Senior VP and General Manager, North America, for Ventana Medical Systems, helping establish tissue and companion diagnostics as standards of care. Mr. Phillips serves on the Board of Trustees of Tucson Medical Center, and he previously was a board member of AdvaMedDx. He holds a B.S. in Marketing from Northern Kentucky University. Following the 2026 Annual Meeting, Mr. Phillips will serve on our Compensation Committee.